Tempest Therapeutics names Nancy Freda-Smith to board
TPST•Tempest Therapeutics named Nancy Freda-Smith as a director, effective Sept. 22, 2026.
1. Board appointment
Tempest Therapeutics named Nancy Freda-Smith as a director, effective Sept. 22, 2026.
